Nykredit A/S »

Biomarin Pharmaceutical shares owned by Nykredit A/S

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Nykredit A/S from 13F filings

Historical chart of Nykredit A/S investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Nykredit A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Nykredit A/S

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 1.5M 0.98

More positions owned by Nykredit A/S

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Citigroup Com New (C)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Tesla Motors (TSLA)
Travelers Companies (TRV)

View all positions for Nykredit A/S

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Oaktree Capital Management
Capstone Investment Advisors
Man Group
Camden Asset Management
Opti Capital Management
MacKay Shields
Jpmorgan Chase & Co
Verition Fund Management
Victory Capital Management
Thrivent Financial for Lutherans
Toronto-Dominion Bank
BlackRock
State Street Corporation
DeepCurrents Investment Group

View all funds holding Biomarin Pharmaceutical